Journal for ImmunoTherapy of Cancer (Nov 2021)
226 Neoantigen-specific TCR-T cells targeting shared hotspot mutations for adoptive cell therapy in common epithelial cancers
- David Torres,
- Yaoyao Shi,
- Drew Deniger,
- Thomas Hunt,
- Ana Korngold,
- Lin-Kin Yong,
- Ugochi Ibekwe,
- Julissa Simmons,
- Phillip Eckels,
- Elizabeth Figueroa,
- Michelle Hotard,
- Frances Adeyemi,
- Tegan Markus,
- Lenka Hurton,
- Matthew Collinson-Pautz,
- Priya Balasubramanian,
- Cathy Wang,
- Jourdan Andersson,
- Lauren Heese,
- Mariam Khalil,
- Emarco Olivares,
- Geraldine Bardelli,
- Kelly O’Brien,
- Haroon Hashmi,
- Alena Chekmasova,
- Raffaele Baffa,
- Tom Spencer,
- Eleanor De Groot
Affiliations
- David Torres
- Aff1 grid.39382.33000000012160926XBaylor College of Medicine Houston TX USA
- Yaoyao Shi
- Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Drew Deniger
- 1Surgery Branch, NCI, Bethesda, MD, USA
- Thomas Hunt
- Ziopharm Oncology, Inc., Boston, MA, USA
- Ana Korngold
- Ziopharm Oncology, Inc., Boston, MA, USA
- Lin-Kin Yong
- Ziopharm Oncology, Inc., Boston, MA, USA
- Ugochi Ibekwe
- Ziopharm Oncology, Inc., Boston, MA, USA
- Julissa Simmons
- Ziopharm Oncology, Inc., Boston, MA, USA
- Phillip Eckels
- Ziopharm Oncology, Inc., Boston, MA, USA
- Elizabeth Figueroa
- Ziopharm Oncology, Inc., Boston, MA, USA
- Michelle Hotard
- Ziopharm Oncology, Inc., Boston, MA, USA
- Frances Adeyemi
- Ziopharm Oncology, Inc., Boston, MA, USA
- Tegan Markus
- Ziopharm Oncology, Inc., Boston, MA, USA
- Lenka Hurton
- Ziopharm Oncology, Inc., Boston, MA, USA
- Matthew Collinson-Pautz
- Ziopharm Oncology, Inc., Boston, MA, USA
- Priya Balasubramanian
- Ziopharm Oncology, Inc., Boston, MA, USA
- Cathy Wang
- Ziopharm Oncology, Inc., Boston, MA, USA
- Jourdan Andersson
- Ziopharm Oncology, Inc., Boston, MA, USA
- Lauren Heese
- Ziopharm Oncology, Inc., Boston, MA, USA
- Mariam Khalil
- Ziopharm Oncology, Inc., Boston, MA, USA
- Emarco Olivares
- Ziopharm Oncology, Inc., Boston, MA, USA
- Geraldine Bardelli
- Ziopharm Oncology, Inc., Boston, MA, USA
- Kelly O’Brien
- Ziopharm Oncology, Inc., Boston, MA, USA
- Haroon Hashmi
- Ziopharm Oncology, Inc., Boston, MA, USA
- Alena Chekmasova
- Ziopharm Oncology, Inc., Boston, MA, USA
- Raffaele Baffa
- Ziopharm Oncology, Inc., Boston, MA, USA
- Tom Spencer
- Ziopharm Oncology, Inc., Boston, MA, USA
- Eleanor De Groot
- Ziopharm Oncology, Inc., Boston, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.226
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
